57
Participants
Start Date
September 29, 2017
Primary Completion Date
March 3, 2021
Study Completion Date
October 27, 2021
Avacopan
Orally administered
Avacopan Matching Placebo
avacopan matching placebo
Clinical Site, Nijmegen
Clinical Site, Nijmegen
Clinical Site, New York
Clinical Site, Rochester
Clinical Site, Philadelphia
Clinical Site, Columbus
Clinical Site, Iowa City
Clinical Site, Chicago
University of Utah, Salt Lake City
Clinical Site, Palo Alto
Clinical Site, Boston
Clinical Trial Site, East Providence
Clinical Site, Antwerp
Clinical Site, Brussels
Clinical Site, Leuven
Clinical Site, Liège
Clinical Site, Vancouver
Clinical Site, Calgary
Clinical Site, Aalborg
Clinical Site, Copenhagen
Clinical Site, Odense
Clinical Site, Boulogne-sur-Mer
Clinical Site, Grenoble
Clinical Site, Paris
Clinical Site, Valenciennes
Clinical Site, Dresden
Clinical Site, Essen
Clinical Site, Hanover
Clinical Site, Lübeck
Clinical Site, Munich
Clinical Site, Dublin
Clinical Site, Bergamo
Clinical Site, Bologna
Clinical Site, Milan
Clinical Site, Parma
Clinical Site, Roma
Clinical Site, Amsterdam
Clinical Site, Leiden
Clinical Site, Burela de Cabo
Clinical Site, Madrid
Clinical Site, London
Clinical Site, Newcastle upon Tyne
Groningen UMC, Groningen
Clinical Site, Barcelona
Clinical Site, Barcelona
Lead Sponsor
Collaborators (1)
Medpace, Inc.
INDUSTRY
Amgen
INDUSTRY